Table 1 Patient characteristics (n = 23)

Age, years

57 (50 to 68)

Sex, male

14 (61)

BSA, m²

2.00 (1.73 to 2.25)

BMI, kg m^− 2

26.3 (24.0 to 30.9)

Prior co-morbidities

 ASA physical status classification

 ASA 2

20 (87)

 ASA 3

3 (13)

 Hypertension

9 (39)

 Type 2 diabetes mellitus

3 (13)

 Asthma / COPD

4 (17)

 Atrial fibrillation

1 (4)

 Coronary artery disease

1 (4)

 Previous valve procedure

2 (9)

 Prior HIPEC-surgery

3 (13)

Medication prior to surgery

 Beta blocker

3 (13)

 ACE inhibitor or AT II receptor inhibitor

7 (30)

Medical state prior to surgery

 Haemoglobin, g l⁻¹

137 (121 to 148)

 Thrombocytes, × 10⁹ l^− 1

300 (236 to 356)

 INR

1.0 (1.0 to 1.1)

 GFR over 59 ml min^− 1 1.73 m^− 2

23 (100)

Diagnose

 Colorectal adenocarcinoma

11 (48)

 Pseudomyxoma peritonei

10 (44)

 Mesothelioma

1 (4)

 Goblet cell carcinoma of the appendix

1 (4)

Surgery

 Peritoneal cancer index

11 (4 to 26)

 Chemotherapy used: mitomycin

22 (96)

 Chemotherapy used: cisplatin and doxorubicin

1 (4)

 Norepinephrine max dose, μg kg⁻¹ min^− 1

0.11 (0.08 to 0.15)

 Dobutamine max dose, μg kg⁻¹ min^− 1

0.96 (0.00 to 1.69)

 OR stay, min

770 (620 to 860)

 ICU length of stay, days

1 (1 to 2)

 Time at tertiary care hospital, days

15 (11 to 20)

 Hospital mortality

0 (0)